Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1470
+0.0005 (0.34%)
Sep 4, 2026, 5:29 PM CET

Prostatype Genomics AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8218741148135
Market Cap Growth
277.15%-76.14%555.78%-76.58%-64.07%-28.46%
Enterprise Value
82573030110
Last Close Price
0.150.3011.1095.00704.882972.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
81.2029.8938.803.0470.9553.75
PB Ratio
12.570.672.220.461.853.76
P/TBV Ratio
-0.732.420.461.853.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
80.818.1237.870.0943.9143.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.200.000.470.030.04
Net Debt / Equity Ratio
-0.06-0.14-0.280.36-0.41-0.53
Net Debt / EBITDA Ratio
0.010.100.24-0.230.371.23
Net Debt / FCF Ratio
0.020.160.21-0.310.381.19
Asset Turnover
0.020.010.040.090.020.07
Inventory Turnover
139.18240.44150.03103.0274.1129.43
Quick Ratio
0.040.401.240.163.156.12
Current Ratio
0.040.441.391.063.276.29
Return on Equity (ROE)
-176.16%-148.35%-141.21%-163.05%-93.74%-48.69%
Return on Assets (ROA)
-55.91%-52.43%-56.00%-61.19%-50.40%-26.31%
Return on Capital Employed (ROCE)
-572.10%-146.80%-122.10%-158.60%-107.80%-42.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.04%-250.63%-55.16%-365.11%-60.02%-11.59%
FCF Yield
-25.46%-135.49%-60.46%-257.41%-57.15%-11.92%
Buyback Yield / Dilution
--2294.78%-1645.51%-343.99%-28.75%-